Zobrazeno 1 - 10
of 6 175
pro vyhledávání: '"Gion, M."'
Autor:
Vaz Batista, M., Pérez-García, J.M., Cortez, P., Garrigós, L., Fernández-Abad, M., Gion, M., Martínez-Bueno, A., Saavedra, C., Teruel, I., Fernandez-Ortega, A., Servitja, S., Ruiz-Borrego, M., de la Haba-Rodríguez, J., Martrat, G., Pérez-Escuredo, J., Alcalá-López, D., Sampayo-Cordero, M., Braga, S., Cortés, J., Llombart-Cussac, A.
Publikováno v:
In ESMO Open September 2024 9(9)
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 15, Pp 1087-1100 (2022)
Massimo Gion,1 Giulia Cardinali,2 Stefano Guzzinati,3 Paolo Morandi,4 Chiara Trevisiol,5 Aline SC Fabricio,5 Massimo Rugge,3,6 Manuel Zorzi3 1Regional Center for Biomarkers, Department of Clinical Pathology, Azienda ULSS 3 Serenissima, Venice, Italy;
Externí odkaz:
https://doaj.org/article/2cd370afc5d942fd9342c50492691849
Autor:
Llombart-Cussac A; Arnau de Vilanova Hospital, Valencia, Spain.; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Pérez-García J; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain., Brasó-Maristany F; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Institut D'Investigacions Biomèdiques August Pi i Sunyer Barcelona, Barcelona, Spain., Paré L; Reveal Genomics, S.L Barcelona, Barcelona, Spain., Villacampa G; Vall d'Hebron Institute of Oncology, Barcelona, Spain., Gion M; Hospital Universitario Ramón y Cajal, Madrid, Spain., Schmid P; Bart Cancer Institute, Queen Mary University of London, London, United Kingdom., Colleoni M; Division of Medical Senology, IEO, European Institute of Oncology, IRCCS, Milan, Italy., Borrego MR; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Galván P; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Institut D'Investigacions Biomèdiques August Pi i Sunyer Barcelona, Barcelona, Spain., Parker JS; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Buckingham W; Reveal Genomics, S.L Barcelona, Barcelona, Spain., Perou CM; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina., Villagrasa P; Reveal Genomics, S.L Barcelona, Barcelona, Spain., Guerrero JA; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Mancino M; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil., Prat A; Reveal Genomics, S.L Barcelona, Barcelona, Spain.; Institut D'Investigacions Biomèdiques August Pi i Sunyer Barcelona, Barcelona, Spain.; Cancer Institute and Blood Diseases, Hospital Clinic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Institute of Oncology (IOB)-Hospital Quirónsalud, Barcelona, Spain., Cortés J; Medica Scientia Innovation Research (MEDSIR)-Oncoclínicas and Co., Jersey City, New Jersey, Sao Paulo, Brazil.; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Sep 13; Vol. 30 (18), pp. 4123-4130.
Autor:
Vaz Batista M; Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA., Pérez-García JM; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain., Garrigós L; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Hospital Universitari Dexeus, Barcelona, Spain., García-Sáenz JÁ; Hospital Clínico San Carlos, Madrid, Spain., Cortez P; IOB Institute of Oncology, Hospital Ruber Internacional, Quiron Group, Madrid, Spain., Racca F; IOB Institute of Oncology, Quiron Group, Madrid, Barcelona, Spain., Blanch S; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA; Fundación Instituto Valenciano de Oncología, Valencia, Spain., Ruiz-Borrego M; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Fernández-Ortega A; Instituto Catalán de Oncología de Hospitalet de Llobregat (ICO), Barcelona, Spain., Fernández-Abad M; Medical Oncologist department, Hospital Ramon y Cajal, Madrid, Spain; Alcalá de Henares University, Faculty of Medicine, Madrid, Spain., Iranzo V; Consorci Hospital General Universitari de València, Valencia, Spain., Gion M; Medical Oncologist department, Hospital Ramon y Cajal, Madrid, Spain., Martrat G; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA., Alcalá-López D; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA., Pérez-Escuredo J; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA., Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain; Universidad Católica de Valencia, Valencia, Spain. Electronic address: antoniollombart@medsir.org., Braga S; Hospital Professor Doutor Fernando Fonseca EPE, Lisbon, Portugal., Cortés J; Medica Scientia Innovation Research (MEDSIR) - Oncoclínicas&Co, Jersey City, NJ, USA; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain. Electronic address: javier.cortes@maj3.health.
Publikováno v:
Med (New York, N.Y.) [Med] 2024 Sep 04. Date of Electronic Publication: 2024 Sep 04.
Autor:
de la Cruz-Merino, L.1,2 (AUTHOR) luis.cruz.sspa@juntadeandalucia.es, Gion, M.2,3 (AUTHOR), Cruz, J.2,4 (AUTHOR), Alonso-Romero, JL.2,5 (AUTHOR), Quiroga, V.2,6 (AUTHOR), Moreno, F.2,7 (AUTHOR), Andrés, R.2,8 (AUTHOR), Santisteban, M.2,9,10 (AUTHOR), Ramos, M.2,11 (AUTHOR), Holgado, E.2,12 (AUTHOR), Cortés, J.2,13,14,15 (AUTHOR), López-Miranda, E.2,3 (AUTHOR), Cortés, A.3 (AUTHOR), Henao, F.1,2 (AUTHOR), Palazón-Carrión, N.1,2 (AUTHOR), Rodriguez, L. M.2,4 (AUTHOR), Ceballos, I.2,4 (AUTHOR), Soto, A.5 (AUTHOR), Puertes, A.5 (AUTHOR), Casas, M.2 (AUTHOR)
Publikováno v:
BMC Cancer. 12/3/2022, Vol. 22 Issue 1, p1-13. 13p.
Autor:
Llombart-Cussac A; Hospital Arnau de Vilanova, FISABIO, Valencia, Spain. antoniollombart@medsir.org.; Universidad Católica de Valencia, Valencia, Spain. antoniollombart@medsir.org.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. antoniollombart@medsir.org., Prat A; Hospital Clínic i Provincial de Barcelona, Barcelona, Spain.; University of Barcelona, Barcelona, Spain.; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain., Pérez-García JM; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; International Breast Cancer Center, Pangea Oncology, QuironSalud Group, Barcelona, Spain., Mateos J; IEC Barcelona, Barcelona, Spain., Pascual T; Hospital Clínic i Provincial de Barcelona, Barcelona, Spain., Escrivà-de-Romani S; Hospital Universitari Vall Hebrón. Vall d'Hebron Institute of Oncology, Barcelona, Spain., Stradella A; ICO L'Hospitalet, Barcelona, Spain., Ruiz-Borrego M; Hospital Virgen del Rocío, Seville, Spain., de Las Heras BB; HCU Valencia, INCLIVA, Universidad de Valencia (CIBERONC-ISCIII, Madrid), Valencia, Spain., Keyaerts M; Vrije Universiteit Brussel, Brussels, Belgium., Galvan P; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain., Brasó-Maristany F; Translational Genomics and Targeted Therapies in Solid Tumors Lab., Barcelona, Spain., García-Mosquera JJ; Dr. Rosell Oncology Institute (IOR), Dexeus University Hospital, Pangaea Oncology, Quironsalud Group, Barcelona, Spain., Guiot T; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Institute Jules Bordet, Brussels, Belgium., Gion M; Hospital Ramón y Cajal, Madrid, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Di Cosimo S; Fondazione IRCCS Istituto Nazionale Dei Tumori, Milano, Italy., Pérez-Escuredo J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., de Frutos MA; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., Cortés J; Universidad Católica de Valencia, Valencia, Spain.; International Breast Cancer Center, Pangea Oncology, QuironSalud Group, Barcelona, Spain.; Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Department of Medicine, Madrid, Spain., Gebhart G; Université Libre de Bruxelles, Hôpital Universitaire de Bruxelles, Institute Jules Bordet, Brussels, Belgium.
Publikováno v:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2024 Jul; Vol. 51 (9), pp. 2733-2743. Date of Electronic Publication: 2024 Apr 08.
Autor:
Gion M; Hospital Universitario Ramón y Cajal, Madrid, Spain., García-Mosquera JJ; Dr. Rosell Oncology Institute (IOR), Dexeus University Hospital, Quironsalud Group, Barcelona, Spain., Pérez-García JM; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA., Peg V; Department of Pathology, Vall d'Hebron University Hospital, Universitat Autònoma de Barcelona (UAB), Barcelona, Spain.; Spanish Biomedical Research Network Centre in Oncology (CIBERONC), Instituto de Salud Carlos III, Madrid, Spain., Ruiz-Borrego M; Hospital Universitario Virgen del Rocío, Sevilla, Spain., Stradella A; Institut Català d'Oncologia L'Hospitalet, Hospitalet de Llobregat, Barcelona, Spain., Bermejo B; Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain., Guerrero JA; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA., López-Montero L; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA., Mancino M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA., Rodríguez-Morató J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA., Antonarelli G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Milan, Italy., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA., Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. antonio.llombart@maj3.health.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA. antonio.llombart@maj3.health.; Hospital Arnau de Vilanova, Valencia, Spain. antonio.llombart@maj3.health.; Universidad Católica de Valencia, Valencia, Spain. antonio.llombart@maj3.health., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain. javier.cortes@maj3.health.; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain. javier.cortes@maj3.health.; Medica Scientia Innovation Research (MEDSIR), Ridgewood, NJ, USA. javier.cortes@maj3.health.; Faculty of Biomedical and Health Sciences, Department of Medicine, Universidad Europea de Madrid, Madrid, Spain. javier.cortes@maj3.health.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2024 Jun; Vol. 205 (3), pp. 589-598. Date of Electronic Publication: 2024 Mar 08.
Autor:
Pérez-García JM; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona 08022, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Cortés J; International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona 08022, Spain; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Ruiz-Borrego M; University Hospital Virgen del Rocío, Sevilla, Spain., Colleoni M; IEO, European Institute of Oncology IRCCS, Milan, Italy., Stradella A; Medical Oncology Department, Institut Català D'Oncologia, L'Hospitalet de Llobregat, Barcelona, Spain., Bermejo B; Medical Oncology, Hospital Clínico Universitario de Valencia, Biomedical Research Institute INCLIVA, Valencia, Spain; Medicine Department, Universidad de Valencia, Spain; Oncology Biomedical Research National Network (CIBERONC-ISCIII), Madrid, Spain., Dalenc F; Oncopole Claudius Regaud- IUCT, Inserm, Department of Medical Oncology, Toulouse, France., Escrivá-de-Romaní S; Medical Oncology Department, Breast Cancer Group, Vall d'Hebron University Hospital, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Calvo Martínez L; Hospital Universitario A Coruña, A Coruña, Spain., Ribelles N; UGC Oncología Intercentros, Hospitales Universitarios Regional y Virgen de la Victoria de Málaga, Instituto de Investigaciones Biomédicas de Málaga (IBIMA), Málaga, Spain., Marmé F; University Hospital Mannheim; Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Cortés A; University Hospital Ramón y Cajal, Madrid, Spain., Albacar C; Hospital Universitari Sant Joan de Reus, Reus, Spain., Gebhart G; Department of Nuclear Medicine, Institut Jules Bordet, Hôpital Universitaire de Bruxelles (HUB), Université Libre de Bruxelles (ULB), Brussels, Belgium., Prat A; Department of Medical Oncology, Hospital Clinic of Barcelona, Barcelona, Spain; Translational Genomics and Targeted Therapies Group, IDIBAPS, Barcelona, Spain; Department of Medicine, University of Barcelona, Barcelona, Spain., Kerrou K; APHP, Tenon Hospital IUC-UPMC, Nuclear Medicine and PET Center Department, Sorbonne University, Paris, France; INSERM U938 (Cancer Biology and Therapeutics), Paris, France., Schmid P; Barts Experimental Cancer Medicine Centre, Barts Cancer Institute, Queen Mary University of London, UK; Barts Hospital NHS Trust, London, UK., Braga S; Unidade de Mama, Instituto CUF de Oncologia, Lisbon, Portugal; NOVA Medical School, Faculdade de Ciências Médicas, Universidade Nova de Lisboa, Lisbon, Portugal., Di Cosimo S; Department of Advanced Diagnostics, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Gion M; University Hospital Ramón y Cajal, Madrid, Spain., Antonarelli G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology (DIPO), University of Milan, Milan, Italy., Popa C; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Szostak E; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Alcalá-López D; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Gener P; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Rodríguez-Morató J; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Mina L; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Sampayo-Cordero M; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain., Llombart-Cussac A; Medica Scientia Innovation Research (MEDSIR), Barcelona, Spain; Hospital Arnau de Vilanova, Universidad Católica de Valencia, Valencia, Spain. Electronic address: antonio.llombart@maj3.health.
Publikováno v:
Lancet (London, England) [Lancet] 2024 Apr 27; Vol. 403 (10437), pp. 1649-1659. Date of Electronic Publication: 2024 Apr 03.